Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Interest Expenses (2020 - 2025)

Historic Interest Expenses for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to $6369.0.

  • Ensysce Biosciences' Interest Expenses rose 5675.61% to $6369.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $24138.0, marking a year-over-year decrease of 9851.41%. This contributed to the annual value of $1.3 million for FY2024, which is 26458.88% up from last year.
  • Ensysce Biosciences' Interest Expenses amounted to $6369.0 in Q3 2025, which was up 5675.61% from $3160.0 recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Interest Expenses registered a high of $1.2 million during Q1 2024, and its lowest value of $1497.0 during Q1 2023.
  • Its 5-year average for Interest Expenses is $170144.8, with a median of $13754.0 in 2021.
  • Its Interest Expenses has fluctuated over the past 5 years, first surged by 8327107.55% in 2024, then crashed by 9969.1% in 2025.
  • Quarter analysis of 5 years shows Ensysce Biosciences' Interest Expenses stood at $12487.0 in 2021, then soared by 315.34% to $51863.0 in 2022, then skyrocketed by 564.83% to $344799.0 in 2023, then plummeted by 96.88% to $10753.0 in 2024, then plummeted by 40.77% to $6369.0 in 2025.
  • Its Interest Expenses stands at $6369.0 for Q3 2025, versus $3160.0 for Q2 2025 and $3856.0 for Q1 2025.